Non-alcoholic fatty liver disease (NAFLD), also termed metabolic dysfunction-associated steatotic liver disease (MASLD), has become one of the fastest-growing liver conditions across the globe. According to the Mayo Clinic, NAFLD primarily affects people who are overweight or obese, or those with metabolic issues such as Type 2 diabetes, high cholesterol, or high blood pressure.

It occurs when excess fat accumulates in the liver, leading to inflammation and potential scarring. It is most prevalent in Middle Eastern and Western countries, where obesity rates continue to rise.

Experts warn that NAFLD can progress into a more severe stage called metabolic dysfunction-associated steatohepatitis (MASH), previously termed NASH. MASH results in liver inflammation and swelling, a condition kno

See Full Page